In mild AD, we found that IL-1β mRNA levels were increased (5, Figures 8(a) and 8(b)), and CD206 and Arg1 mRNA levels were reduced (P < 0.01, Figures 8(c) and 8(d)) in the AD group compared with the WT group. This evidence concerns the gene MRC1 and Alzheimer disease.